MedTrace Logo

Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping

NCT01772043 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2015-07-28

No results posted yet for this study

Summary

We will utilize the Cooperative International Neuromuscular Research Group (CINRG) network to collect and store tissue and blood from patients with Duchenne muscular dystrophy (DMD) with specific genetic mutations within the dystrophin gene that could be treated by antisense oligonucleotide (AO) drugs.

Conditions

Sponsors & Collaborators

  • Cooperative International Neuromuscular Research Group

    lead NETWORK

Eligibility

Min Age
4 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01772043 on ClinicalTrials.gov